首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Protection of Mice Against Lethal Rabies Virus Challenge Using Short Interfering RNAs (siRNAs) Delivered Through Lentiviral Vector
【2h】

Protection of Mice Against Lethal Rabies Virus Challenge Using Short Interfering RNAs (siRNAs) Delivered Through Lentiviral Vector

机译:使用通过慢病毒载体传递的短干扰RNA(siRNA)保护小鼠免受狂犬病病毒的致命攻击。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The antiviral potential of small interfering RNAs (siRNAs) targeting rabies virus (RV) polymerase (L) and nucleoprotein (N) genes delivered through lentiviral vector was investigated. For in vitro evaluation, siRNAs expressing BHK-21 cell lines (BHK-L and BHK-N) were developed using transduction with Lenti-L and Lenti-N lentiviruses encoding siRNAs against RV-L and N genes, respectively. When these cell lines were challenged in vitro with RV Pasteur virus-11 (PV-11) strain, there was reduction in number of RV-specific foci and target gene transcripts indicating inhibitory effect on RV multiplication. For in vivo evaluation, mice were treated intracerebrally with lentiviruses and challenged with 20 LD of RV challenge virus standard-11 (CVS-11) strain by intramuscular route in masseter muscle. Five out of eight mice treated with Lenti-N survived indicating 62.5 % protection. The control and Lenti-L-treated mice died within 7–10 days indicating lethal nature of challenge virus and no protection. These results demonstrated that siRNA targeting RV-N could not only inhibit RV multiplication, but also conferred protection in mice against lethal RV challenge. These findings have implication on therapeutic use of siRNA targeting RV-N against RV infection.
机译:研究了靶向慢病毒载体的狂犬病病毒(RV)聚合酶(L)和核蛋白(N)基因的小干扰RNA(siRNA)的抗病毒潜力。为了进行体外评估,使用分别编码针对RV-L和N基因的siRNA的Lenti-L和Lenti-N慢病毒进行转导,开发了表达BHK-21细胞系(BHK-L和BHK-N)的siRNA。当这些细胞系在体外用RV Pasteur病毒11(PV-11)菌株攻击时,RV特异性病灶和靶基因转录物的数量减少,表明对RV增殖具有抑制作用。为了进行体内评估,将小鼠用慢病毒进行脑内治疗,并在咬肌中通过肌内途径用20 LD的RV挑战病毒标准11(CVS-11)菌株进行攻击。用Lenti-N治疗的八只小鼠中有五只存活下来,表明62.5%的保护率。对照和经Lenti-L处理的小鼠在7-10天内死亡,表明攻击病毒具有致命性,没有任何保护作用。这些结果表明靶向RV-N的siRNA不仅可以抑制RV增殖,而且还可以在小鼠中提供针对致命RV攻击的保护作用。这些发现对靶向针对RV感染的RV-N的siRNA的治疗用途具有意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号